100 KING STREET WEST, TORONTO, A6
2026 Annual Meeting Results; KPMG LLP Appointed as Auditor
Medicus Pharma Ltd. Enters $22.86M Note Purchase Agreement with Streeterville...
Annual Report to Security Holders
Amendment to Equity Distribution Agreement - Medicus Pharma Increases Offerin...
Medicus Pharma Ltd. Completes Unregistered Sales of Common Shares
Equity Distribution Agreement with Maxim Group and Yorkville Securities
Enters Into $5.1 Million Warrant Inducement
Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
Q1
Amended Annual Report
FY 2025
Q3
Q2
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
PRER14A
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Regulation A Offering Circular Supplement (Annual Report)